This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Motor neuron disease (with DMD)
MND
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
31 |
4. Check minimum number of eventsNone |
31 |
5. Include endpoints |
705 |
6. Filter based on genotype QC (FinnGen only) |
705 |
Extra metadata
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- G710
- Name in latin
- Dystrophia musculorum gravis (Duchenne)
Similar endpoints
↥List of similar endpoints to
Motor neuron disease (with DMD)
based on the number of shared cases.
Similar with more cases:
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 705 | 277 | 428 |
| Unadjusted period prevalence (%) | 0.15 | 0.09 | 0.19 |
| Median age at first event (years) | 66.98 | 67.13 | 66.89 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 632
- Matched controls
- 6320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G12.2
ICD-10 Finland
Motor neuron disease
+∞
323.0
579
*
N07XX02
ATC
riluzole; oral
+∞
166.1
152
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
102.1
138.5
149
19
N99
ICPC
Neurological disease other
419.6
136.3
132
*
R47.1
ICD-10 Finland
Dysarthria and anarthria
1551.8
133.3
125
*
J96.1
ICD-10 Finland
Chronic respiratory failure
37.6
120.6
155
54
JDB10
NOMESCO Finland
Percutaneous gastrostomy
101.8
120.6
130
16
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
26.8
107.1
151
73
R13
ICD-10 Finland
Dysphagia
17.2
94.4
156
118
Z51.5
ICD-10 Finland
Palliative care
11.8
84.9
168
188
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
24.9
81.7
117
57
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
22.2
76.7
114
62
N28
ICPC
Limited function/disability (N)
104.4
76.0
82
9
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
11.5
72.6
144
158
TAB00
NOMESCO Finland
Lumbar puncture
61.7
69.9
81
15
R4130
NOMESCO Finland
Speech therapy
54.4
68.4
81
17
G47.3
ICD-10 Finland
Sleep apnoea
24.6
66.4
95
45
A28
ICPC
Limited function/disability NOS
7.0
65.2
182
347
XG466
NOMESCO Finland
Sleep oxymetry
42.0
65.1
81
22
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
74.6
59.5
67
10
SPAT1229
SPAT
Assessment of need for aid
10.6
58.2
119
135
R5140
NOMESCO Finland
Monitoring the use of the aid
16.6
56.7
93
65
L28
ICPC
Limited function/disability (L)
6.0
54.8
172
373
WX725
NOMESCO Finland
Noninvasive ventilation
11.6
50.3
97
97
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
46.4
44
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
5.0
45.0
163
408
R1250
NOMESCO Finland
Evaluation of functional capability
47.1
42.9
52
12
TJD20
NOMESCO Finland
Change of gastrostomy tube
224.3
41.4
42
*
AA1AD
NOMESCO Finland
CT of head and brain
5.4
41.3
137
308
N03AE01
ATC
clonazepam; systemic
15.2
39.3
66
48
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
207.3
38.2
39
*
R4120
NOMESCO Finland
Occupational therapy
10.0
37.4
77
86
R1260
NOMESCO Finland
Evaluation of communicative skills
38.9
37.4
47
13
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
10.7
36.8
73
76
N29
ICPC
Neurological sympt/complt other
56.0
35.8
42
8
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.1
35.4
91
146
S06.0
ICD-10 Finland
Concussion
27.4
33.7
46
18
M03BX01
ATC
baclofen; systemic
67.2
33.4
38
6
R5599
NOMESCO Finland
Other rehabilitation service
17.1
32.6
52
33
SPAT1231
SPAT
Assessment of adjustments needed in living environment
25.4
32.3
45
19
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
13.2
32.1
57
47
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
41.4
31.5
39
10
XA800
NOMESCO Finland
Neuropsychological investigation
63.4
31.4
36
6
N18
ICPC
Paralysis/weakness
63.4
31.4
36
6
N19
ICPC
Speech disorder
37.6
30.9
39
11
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
48.9
30.9
37
8
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
30.4
29
*
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
9.7
29.9
62
70
R4190
NOMESCO Finland
Nutritional therapy
8.9
29.3
64
79
SPAT1216
SPAT
Assessment of functional ability
3.9
28.5
130
392
D21
ICPC
Swallowing problem
41.0
28.3
35
9
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
104.8
27.9
30
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
18.6
27.4
42
24
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
7.3
27.4
68
103
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
27.3
26
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
12.5
27.2
49
42
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
26.2
25
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.4
25.3
80
166
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.7
24.3
115
354
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
90.2
23.8
26
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.7
23.2
112
350
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
21.0
21.9
32
16
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
+∞
20.9
20
*
N05BA04
ATC
oxazepam; oral
3.1
20.9
130
489
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
9.5
20.9
43
48
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
79.5
20.8
23
*
N06AB10
ATC
escitalopram; oral
4.0
20.7
88
246
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
20.6
168
749
G56.0
ICD-10 Finland
Carpal tunnel syndrome
11.5
20.4
38
35
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
7.0
20.4
51
78
XA402
NOMESCO Finland
ENMG
15.1
20.1
33
23
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
19.9
177
828
T05
ICPC
Feeding problem of adult
+∞
19.9
19
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.0
19.8
56
101
SPAT1234
SPAT
Support of social functional capacity
8.0
19.7
45
60
N03AX12
ATC
gabapentin; oral
3.7
18.9
88
265
N05AH04
ATC
quetiapine; oral
5.7
18.9
55
103
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
18.8
18
*
N06AX11
ATC
mirtazapine; oral
2.7
18.8
151
662
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
5.8
18.7
54
100
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
18.7
192
964
SPAT1245
SPAT
Provision of support and information to patient’s family members
6.5
17.9
47
77
XG416
NOMESCO Finland
Measurement of maximal airway pressure
+∞
17.8
17
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
17.8
17
*
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
17.8
17
*
R25.3
ICD-10 Finland
Fasciculation
37.9
17.7
22
6
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.9
17.4
58
127
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
9.7
17.3
35
38
Z31.5
ICD-10 Finland
Genetic counselling
6.6
17.3
45
73
N06AB04
ATC
citalopram; systemic
3.2
17.1
96
333
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.8
16.9
36
43
XX9TE
NOMESCO Finland
Compementary ultrasound examination
65.1
16.8
19
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
11.2
16.6
31
29
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
14.8
16.4
27
19
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
16.3
75
223
Z50.5
ICD-10 Finland
Speech therapy
21.6
16.1
23
11
ACC51
NOMESCO Finland
Release of median nerve
61.6
15.8
18
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
15.7
15
*
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
15.7
15
*
SPAT1254
SPAT
Administration of medicine
2.9
14.9
97
372
NXL00
NOMESCO Finland
Biopsy of muscle
58.1
14.8
17
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
14.6
14
*
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
14.6
14
*
RS314
NOMESCO Finland
NA
+∞
14.6
14
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
82.0
14.6
16
*
GX2D5
NOMESCO Finland
Sleep oximetry
153.3
14.5
15
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
37.0
14.5
18
5
N02AA01
ATC
morphine; systemic, rectal
7.7
14.4
33
45
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
19.7
14.3
21
11
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
22.9
14.3
20
9
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
30.8
13.9
18
6
F80.1
ICD-10 Finland
Expressive language disorder
54.6
13.9
16
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
13.6
13
*
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
26.4
13.4
18
7
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
13.3
164
878
A06AD11
ATC
lactulose; oral
2.6
13.0
102
434
N05BA06
ATC
lorazepam; systemic, sublingual
5.7
13.0
37
68
G20
ICD-10 Finland
Parkinson disease
71.3
12.6
14
*
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
71.3
12.6
14
*
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
32.7
12.6
16
5
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
17.8
12.6
19
11
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
12.5
12
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
12.5
12
*
RS340
NOMESCO Finland
NA
+∞
12.5
12
*
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
+∞
12.5
12
*
RK110
NOMESCO Finland
NA
20.5
12.5
18
9
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
132.4
12.5
13
*
UJC01
NOMESCO Finland
Scopy of lower throat
16.3
12.2
19
12
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
27.3
12.1
16
6
G62.8
ICD-10 Finland
Other specified polyneuropathies
66.2
11.6
13
*
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
122.1
11.5
12
*
J96.0
ICD-10 Finland
Acute respiratory failure
10.8
11.3
21
20
G56.2
ICD-10 Finland
Lesion of ulnar nerve
20.5
11.2
16
8
R5110
SPAT
NA
7.6
11.0
25
34
N03AG01
ATC
valproic acid; systemic, rectal
15.8
10.9
17
11
N06DA02
ATC
donepezil; oral
28.6
10.8
14
5
N03AF01
ATC
carbamazepine; oral, rectal
7.2
10.6
25
36
N05AX08
ATC
risperidone; systemic
10.3
10.6
20
20
WX722
NOMESCO Finland
PEEP
6.4
10.5
27
44
RS211
NOMESCO Finland
NA
111.7
10.4
11
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
10.4
10
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
+∞
10.4
10
*
N07AA02
ATC
pyridostigmine; systemic
+∞
10.4
10
*
Z93.1
ICD-10 Finland
Gastrostomy status
+∞
10.4
10
*
RS142
NOMESCO Finland
NA
+∞
10.4
10
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.0
10.3
21
24
XG410
NOMESCO Finland
Flow-volume spirometry
4.3
10.2
37
90
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
13.4
10.2
17
13
N05BA01
ATC
diazepam; systemic, rectal
2.8
10.1
67
259
R53
ICD-10 Finland
Malaise and fatigue
2.4
10.1
90
410
R06.0
ICD-10 Finland
Dyspnoea
2.0
10.1
139
771
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
14.9
10.0
16
11
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
12.4
9.9
17
14
R4110
NOMESCO Finland
Physiotherapy
1.9
9.7
153
889
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
13.6
9.7
16
12
J96.9
ICD-10 Finland
Respiratory failure, unspecified
55.8
9.7
11
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
55.8
9.7
11
*
N05AN01
ATC
lithium; oral
101.4
9.4
10
*
RS310
NOMESCO Finland
NA
101.4
9.4
10
*
XA421
NOMESCO Finland
Nocturnal polygraphy
101.4
9.4
10
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
17.8
9.4
14
8
A210_
NOMESCO Finland
NA
+∞
9.4
9
*
K11.72
ICD-10 Finland
Xerostomia
+∞
9.4
9
*
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
9.4
9
*
A120_
NOMESCO Finland
NA
+∞
9.4
9
*
G71.03
ICD-10 Finland
Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker
+∞
9.4
9
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
9.4
9
*
RS221
NOMESCO Finland
NA
10.9
9.3
17
16
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
9.3
111
579
A98
ICPC
Health maint/preventive medicine
0.5
9.2
446
5137
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
13.9
9.2
15
11
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.0
9.2
36
95
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
9.1
236
1619
SPAT1240
SPAT
Therapeutic discussion
3.8
9.1
37
101
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
9.1
48
161
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
15.9
9.1
14
9
U04
ICPC
Incontinence urine
4.5
9.0
31
72
N06AA09
ATC
amitriptyline; systemic
3.2
8.9
47
157
RS230
NOMESCO Finland
NA
24.4
8.9
12
5
R49.08
ICD-10 Finland
Other specified dysphonia
7.3
8.8
20
28
S01.0
ICD-10 Finland
Open wound of scalp
3.1
8.7
47
160
N87
ICPC
Parkinsonism
50.7
8.7
10
*
RS122
NOMESCO Finland
NA
50.7
8.7
10
*
L99
ICPC
Musculoskeletal disease other
7.8
8.7
19
25
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
8.6
94
472
N05AH03
ATC
olanzapine; systemic
16.5
8.6
13
8
Z50.1
ICD-10 Finland
Other physical therapy
3.5
8.6
39
117
RS222
NOMESCO Finland
NA
10.2
8.6
16
16
K90
ICPC
Stroke/cerebrovascular accident
20.3
8.5
12
6
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
91.2
8.4
9
*
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
91.2
8.4
9
*
WX723
NOMESCO Finland
CPAP therapy
91.2
8.4
9
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
8.3
8
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
+∞
8.3
8
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
8.3
8
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
8.3
8
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
8.3
8
*
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
+∞
8.3
8
*
N81
ICPC
Injury nervous system other
+∞
8.3
8
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
8.7
8.3
17
20
SPAT1167
SPAT
Insertion of urinary catheter
4.5
8.3
28
64
WYA20
NOMESCO Finland
Home visit
14.7
8.2
13
9
SPAT1262
SPAT
Handing over of treatment supplies
2.0
8.2
107
577
SPAT1139
SPAT
Nutrition survey
5.2
8.1
24
48
RS311
NOMESCO Finland
NA
33.8
8.1
10
*
N02AA05
ATC
oxycodone; systemic
2.1
8.1
93
478
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
5.7
8.0
22
40
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.5
8.0
36
107
M48.0
ICD-10 Finland
Spinal stenosis
2.4
8.0
66
289
N06AX21
ATC
duloxetine; oral
3.4
7.9
36
109
N03AX16
ATC
pregabalin; oral
2.0
7.9
99
527
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.6
7.8
16
19
R42
ICD-10 Finland
Dizziness and giddiness
2.1
7.8
95
499
A04
ICPC
Weakness/tiredness general
2.6
7.8
57
235
Z73.6
ICD-10 Finland
Limitation of activities due to disability
15.2
7.7
12
8
RS313
NOMESCO Finland
NA
45.5
7.7
9
*
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
80.9
7.4
8
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
80.9
7.4
8
*
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
13.5
7.4
12
9
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.6
7.4
31
88
H02AB13
ATC
deflazacort; oral
+∞
7.3
7
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
7.3
7
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
+∞
7.3
7
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
7.3
7
*
A220_
NOMESCO Finland
NA
+∞
7.3
7
*
G72.8
ICD-10 Finland
Other specified myopathies
+∞
7.3
7
*
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
7.3
7
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
7.3
7
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
7.3
7
*
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
7.3
7
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
+∞
7.3
7
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
+∞
7.3
7
*
34800
ICD-8 Finland
Motor neurone disease, Amyotrophic lateral sclerosis
+∞
7.3
7
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
7.3
7
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
15.9
7.2
11
7
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.1
7.2
38
129
N04BC05
ATC
pramipexole; oral
3.4
7.2
33
101
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
30.4
7.2
9
*
S28
ICPC
Limited function/disability (S)
30.4
7.2
9
*
Z75.5
ICD-10 Finland
Holiday relief care
30.4
7.2
9
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
10.2
7.1
13
13
L19
ICPC
Muscle symptom/complaint NOS
5.3
7.0
20
39
P29
ICPC
Psychological sympt/compl other
6.8
6.8
16
24
W19
ICD-10 Finland
Unspecified fall
2.6
6.8
48
194
JDB00
NOMESCO Finland
Gastrostomy
40.5
6.8
8
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
16.9
6.8
10
6
N05CF01
ATC
zopiclone; oral
1.7
6.7
156
1021
N06DX01
ATC
memantine; oral
22.8
6.7
9
*
RK320
NOMESCO Finland
NA
12.4
6.6
11
9
R41.0
ICD-10 Finland
Disorientation, unspecified
8.8
6.6
13
15
G44.2
ICD-10 Finland
Tension-type headache
3.2
6.5
32
104
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
6.5
32
104
130
Kela drug reimbursment
Malignant tumour
0.3
6.4
11
387
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
6.4
41
155
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
70.5
6.4
7
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
70.5
6.4
7
*
N05AX12
ATC
aripiprazole; systemic
70.5
6.4
7
*
RS121
NOMESCO Finland
NA
70.5
6.4
7
*
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
70.5
6.4
7
*
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
+∞
6.3
6
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
6.3
6
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
6.3
6
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
6.3
6
*
RK410
NOMESCO Finland
NA
+∞
6.3
6
*
N86
ICPC
Multiple sclerosis
+∞
6.3
6
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
+∞
6.3
6
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
6.3
6
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
6.3
6
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
+∞
6.3
6
*
G54.9
ICD-10 Finland
Nerve root and plexus disorder, unspecified
+∞
6.3
6
*
M54.1
ICD-10 Finland
Radiculopathy
4.2
6.2
22
54
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
26.9
6.2
8
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
6.2
23
59
R06.5
ICD-10 Finland
Mouth breathing
3.1
6.2
32
108
SPAT1252
SPAT
Overall medication plan or its review
2.8
6.1
37
139
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
68
12
62.61
121.85
1.0
1.0
—
—
—
0
0
65
11
64.99
117.26
1.0
1.0
—
—
—
0
0
76
31
27.36
109.16
1.1
1.5
9.1
195.2
e6/l
0.47
62
21
75
31
26.95
107.18
1.2
1.5
718.5
821.9
e6/l
0.04
62
22
351
1109
5.31
106.58
2.5
1.8
480.6
194.3
u/l
1.59
335
1020
150
253
7.26
89.01
5.0
4.2
3.2
1.7
mmol/l
4.01
137
186
155
271
7.05
88.88
5.3
4.2
5.7
5.0
kpa
10.72
149
247
69
8
95.51
63.19
1.0
1.0
—
—
—
0
0
66
9
80.54
59.21
1.1
1.0
—
—
—
0
0
79
106
8.27
56.66
5.5
4.0
28.1
24.4
mmol/l
5.76
69
90
130
371
4.07
40.75
1.6
2.7
67.8
66.2
g/l
1.90
119
343
157
536
3.48
37.61
5.5
7.0
5.8
5.1
kpa
7.26
152
507
156
536
3.45
36.95
5.5
7.0
10.6
12.5
kpa
8.22
150
507
151
534
3.33
33.94
5.5
7.1
4.0
0.8
mmol/l
17.69
131
417
69
155
4.83
29.14
1.3
1.9
2.7
3.2
g/l
4.14
46
129
71
167
4.62
28.34
1.3
1.8
6.5
7.5
g/l
4.42
46
129
71
167
4.62
28.34
1.3
1.8
—
—
—
0
0
71
167
4.62
28.34
1.3
1.8
3.6
3.7
g/l
0.08
46
125
68
162
4.54
26.69
1.1
1.8
10.2
10.5
g/l
0.25
47
139
56
126
4.74
23.54
1.7
2.3
318.4
321.2
ug/l
0.01
50
117
411
5346
0.45
23.27
3.6
4.7
2.8
2.7
mmol/l
1.03
346
4855
400
5227
0.46
22.08
3.4
4.2
4.8
4.6
mmol/l
1.48
338
4783
396
5186
0.46
21.77
3.5
4.2
1.5
1.5
mmol/l
0.45
336
4712
388
5002
0.50
17.51
3.2
3.8
1.3
1.2
mmol/l
0.06
329
4506
157
787
2.28
16.87
1.7
1.7
1165.8
1163.2
nmol/l
0.01
124
578
39
86
4.74
16.77
2.6
2.5
18.5
15.8
%
4.17
29
47
48
128
3.95
16.18
1.3
1.7
0.0
0.0
g/l
0.50
43
116
49
136
3.80
15.62
1.1
1.6
40.0
37.2
g/l
2.49
43
119
310
2054
1.91
15.32
3.5
5.0
35.6
35.0
g/l
1.06
292
1909
46
126
3.84
14.94
1.1
1.7
0.0
0.0
g/l
0.00
41
114
50
146
3.61
14.81
1.4
2.0
0.2
1.6
g/l
1.77
43
124
141
716
2.21
14.50
2.4
3.8
0.8
0.8
mmol/l
0.34
122
665
45
125
3.78
14.33
1.1
1.7
0.0
0.0
g/l
0.00
40
114
147
763
2.17
14.30
1.8
1.8
—
—
—
0
0
387
4854
0.55
13.22
4.6
5.5
38.2
39.8
mmol/mol
3.18
344
4441
15
15
10.20
13.17
3.9
2.2
71.3
66.5
ug/l
0.08
15
15
338
2382
1.80
13.09
6.1
6.5
1.2
1.2
mmol/l
3.51
280
2034
35
93
3.91
11.87
2.4
2.2
142.3
128.8
g/l
2.65
30
65
306
2163
1.73
11.20
6.3
5.8
1.2
1.2
mmol/l
0.53
277
1949
426
5127
0.57
11.16
3.9
4.4
5.8
5.9
mmol/l
1.13
379
4599
371
2808
1.68
10.23
5.0
4.2
6.4
6.8
mmol/l
3.51
356
2626
524
5927
0.55
10.22
22.9
18.5
135.2
135.9
g/l
0.48
518
5806
524
5925
0.55
10.15
22.7
18.4
4.5
4.5
e12/l
1.04
507
5688
524
5922
0.55
10.05
22.7
18.4
246.0
241.8
e9/l
0.89
510
5704
412
4956
0.59
9.98
13.8
12.5
94.5
76.0
ml/min/173m2
23.73
337
3976
91
481
2.02
8.23
4.1
4.0
4.2
1.7
mmol/l
5.88
75
358
405
4811
0.63
8.13
18.3
14.1
39.1
39.4
%
0.20
247
3370
10
11
9.21
8.10
1.0
1.0
—
—
—
0
0
98
537
1.96
8.00
1.8
1.6
—
—
—
0
0
502
5668
0.60
7.98
9.6
9.4
37.8
25.6
u/l
4.22
484
5409
100
1667
0.53
7.83
3.0
3.8
10.8
7.8
mg/mmol
0.35
54
1065
106
606
1.88
7.61
4.3
5.6
1.1
1.1
mmol/l
0.28
96
560
96
539
1.90
7.28
1.8
1.7
—
—
—
0
0
148
963
1.68
6.80
1.4
1.7
451.6
26263042.5
pmol/l
1.04
123
792
10
6
16.88
6.76
1.4
2.0
5.6
4.2
mmol/l
—
10
6
93
1489
0.57
6.09
2.5
3.3
0.8
0.9
ug/l
0.20
67
1033
47
222
2.20
5.71
4.2
3.0
0.6
0.6
%
0.14
42
214
53
268
2.06
5.42
6.5
9.6
27.1
24.6
mmol/l
6.14
46
251
73
414
1.85
5.37
6.8
7.5
1.2
1.3
mmol/l
0.90
68
405
41
189
2.24
5.29
1.7
2.0
—
—
—
0
0
255
1975
1.46
5.21
1.8
1.9
94.6
94.2
pmol/l
0.05
140
993
8
6
13.46
5.09
2.5
1.5
—
—
—
0
0
30
123
2.50
5.02
1.4
1.2
—
—
—
0
0
61
336
1.89
4.92
4.1
3.7
63.8
91.3
ng/l
2.18
54
300
36
164
2.26
4.80
1.6
1.9
—
—
—
0
0
51
269
1.97
4.67
4.5
4.5
26.2
23.7
mmol/l
4.51
45
246
202
1542
1.43
4.32
2.9
3.9
2.4
2.4
mmol/l
1.14
178
1328
188
1430
1.43
4.07
2.9
3.2
43.7
37.5
u/l
0.43
182
1358
8
10
8.08
4.07
4.5
4.1
—
—
—
0
0
7
7
10.08
4.01
1.3
1.0
—
—
—
0
0
7
7
10.08
4.01
1.1
1.0
—
—
—
0
0
7
7
10.08
4.01
1.1
1.0
—
—
—
0
0
79
500
1.65
3.99
4.5
2.7
—
—
—
0
0
27
118
2.34
3.99
1.6
1.7
—
—
—
0
0
7
8
8.82
3.78
1.1
1.0
—
—
—
0
0
7
8
8.82
3.78
1.1
1.0
—
—
—
0
0
53
309
1.77
3.61
1.5
1.5
—
—
—
0
0
157
2012
0.72
3.32
3.8
4.6
22.2
21.9
%
0.11
81
1092
51
302
1.74
3.31
1.7
1.5
—
—
—
0
0
197
2434
0.74
3.30
3.7
5.5
6.5
3.8
ug/l
0.41
168
2190
7
11
6.41
3.19
1.0
1.1
—
—
—
0
0
11
34
3.27
3.07
1.4
1.0
—
—
—
0
0
513
5515
0.74
2.98
18.7
14.9
3.9
4.0
mmol/l
6.95
500
5333
512
5503
0.75
2.94
18.9
14.7
139.7
139.7
mmol/l
0.29
503
5330
51
314
1.67
2.91
1.6
2.4
414.6
386.8
nmol/l
0.50
44
288
9
23
3.95
2.78
2.0
4.6
—
—
—
0
0
5
6
8.38
2.75
3.0
1.5
1.1
1.1
mmol/l
—
5
6
37
617
0.58
2.74
2.8
4.9
15.8
45.1
ug/l
0.80
30
518
212
1740
1.31
2.71
4.3
3.1
65.3
68.4
ng/l
0.05
190
1216
361
3176
1.28
2.70
5.3
3.9
52.0
1896.4
e6/l
—
7
42
99
1326
0.71
2.66
2.8
2.7
11425.0
8749.7
umol/l
0.16
83
1150
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
19
88
2.19
2.53
1.6
1.5
—
—
—
0
0
48
304
1.62
2.49
9.5
9.1
91.0
94.5
%
1.78
48
304
325
2842
1.27
2.48
6.4
9.0
4.1
4.1
e9/l
0.00
281
2400
23
423
0.53
2.42
1.5
1.8
—
—
—
0
0
6
12
5.03
2.40
1.0
1.2
—
—
—
0
0
20
97
2.09
2.39
1.1
1.1
—
—
—
0
0
10
36
2.80
2.21
1.1
1.1
—
—
—
0
0
9
30
3.03
2.15
1.8
1.2
—
—
—
0
0
9
30
3.03
2.15
1.8
1.2
—
—
—
0
0
24
130
1.88
2.15
1.4
1.6
—
—
—
0
0
14
62
2.28
2.09
1.9
3.4
3.9
3.9
e9/l
0.01
14
62
66
469
1.45
2.07
3.3
2.8
155.0
231.6
ng/l
1.05
60
428
6
15
4.02
2.04
1.7
2.4
—
—
—
0
0
12
50
2.42
2.03
2.2
1.9
89.3
89.2
%
0.02
12
50
7
21
3.36
1.97
1.3
2.0
—
—
—
0
0
32
505
0.62
1.95
1.4
1.4
—
—
—
0
0
14
64
2.21
1.95
2.0
3.8
60.6
55.7
%
0.88
14
64
12
52
2.33
1.88
1.1
1.5
—
—
—
0
0
12
52
2.33
1.88
1.1
1.5
—
—
—
0
0
12
52
2.33
1.88
1.1
1.5
—
—
—
0
0
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
19
101
1.91
1.82
1.3
1.2
—
—
—
0
0
19
101
1.91
1.82
1.3
1.2
—
—
—
0
0
16
80
2.02
1.81
1.8
1.4
—
—
—
0
0
50
347
1.47
1.79
1.4
1.4
1.5
1.4
%
0.31
42
296
121
972
1.30
1.78
3.5
3.6
797.7
576.2
ng/l
0.12
105
823
398
3641
1.21
1.78
3.9
3.7
10.6
13.4
mm/h
4.38
372
3321
6
18
3.35
1.75
2.5
1.2
—
—
—
0
0
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
8
30
2.69
1.72
1.1
1.6
—
—
—
0
0
22
126
1.77
1.69
1.5
1.6
—
—
—
0
0
8
31
2.60
1.66
1.0
1.2
—
—
—
0
0
14
69
2.05
1.65
1.8
1.4
—
—
—
0
0
208
2382
0.82
1.62
5.5
4.4
0.0
0.0
estimate
0.00
41
401
211
1828
1.22
1.62
2.8
2.2
77.4
79.2
nmol/l
0.39
183
1607
284
2537
1.20
1.58
4.8
6.7
12.6
13.2
umol/l
0.29
272
2400
27
169
1.62
1.54
1.9
2.8
—
—
—
0
0
5
125
0.40
1.51
1.6
3.3
14.4
357.5
u/ml
—
5
117
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
6
22
2.74
1.43
1.2
1.7
—
—
—
0
0
240
2683
0.84
1.40
2.8
2.4
—
—
—
0
0
14
74
1.91
1.40
1.7
1.4
—
—
—
0
0
5
124
0.40
1.37
1.6
1.3
—
—
—
0
0
15
82
1.85
1.36
1.5
1.1
—
—
—
0
0
5
17
2.95
1.36
1.2
3.2
—
—
—
0
0
6
131
0.45
1.29
1.0
1.6
—
—
—
0
0
49
650
0.74
1.28
1.1
1.2
11.2
19.9
u/ml
0.57
18
235
9
44
2.06
1.27
3.4
2.3
—
—
—
0
0
37
262
1.44
1.25
1.4
1.3
—
—
—
0
0
318
2915
1.17
1.23
3.2
2.7
38.9
51.4
u/l
3.41
298
2655
216
2414
0.85
1.23
3.9
3.1
0.0
0.0
estimate
0.00
41
392
6
26
2.32
1.19
2.5
1.5
—
—
—
0
0
6
26
2.32
1.19
2.5
1.5
—
—
—
0
0
10
50
2.01
1.17
1.2
1.8
—
—
—
0
0
16
95
1.70
1.14
1.5
1.5
—
—
—
0
0
212
2360
0.85
1.13
4.0
3.1
0.0
0.0
estimate
0.00
40
390
126
1081
1.20
1.07
1.4
1.5
20.7
20.6
nmol/l
0.02
116
892
7
33
2.13
1.05
2.3
1.4
—
—
—
0
0
11
60
1.85
1.03
1.0
1.1
—
—
—
0
0
9
48
1.89
1.00
1.2
1.8
—
—
—
0
0
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
110
943
1.20
0.95
1.8
1.6
1.3
1.5
mg/l
0.29
88
730
15
93
1.63
0.94
1.1
1.2
—
—
—
0
0
6
28
2.15
0.91
5.2
2.6
24.3
18.7
nmol/l
—
6
28
16
103
1.57
0.88
1.0
1.1
—
12.3
—
0
7
35
457
0.75
0.87
2.8
2.3
27.8
48.4
u/l
1.31
28
395
8
44
1.83
0.86
1.4
1.4
—
—
—
0
0
200
1817
1.14
0.83
3.9
3.2
—
—
—
0
0
6
111
0.54
0.83
1.3
1.2
—
—
—
0
0
0
26
0.00
0.78
0.0
5.8
—
71.6
—
0
5
46
370
1.26
0.75
2.5
4.0
1.2
1.2
mmol/l
1.04
37
324
100
872
1.17
0.74
2.9
3.5
2.5
2.5
mmol/l
0.43
83
761
7
39
1.80
0.72
1.1
1.2
—
—
—
0
0
169
1535
1.13
0.71
2.9
2.9
1015.6
1566.2
ng/l
1.34
139
1319
14
93
1.52
0.70
2.1
1.4
26.9
34.0
iu/l
—
9
82
368
3498
1.11
0.69
3.3
3.3
15.3
14.9
pmol/l
1.78
343
3121
5
27
1.86
0.68
1.8
1.2
—
—
—
0
0
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
7
42
1.67
0.68
1.0
1.4
—
114.3
—
0
7
5
92
0.54
0.67
1.6
1.5
—
—
—
0
0
96
842
1.16
0.67
1.2
1.2
0.7
1.4
u/ml
1.60
16
205
156
1416
1.13
0.67
3.7
3.3
0.7
0.6
e6/l
0.22
122
1061
18
129
1.41
0.64
1.6
1.6
0.6
0.1
iu/ml
—
5
28
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
5
90
0.55
0.56
2.4
6.5
—
429.9
—
0
12
6
37
1.63
0.55
1.0
1.5
—
—
—
0
0
168
1816
0.90
0.55
4.1
3.3
—
—
—
0
0
19
142
1.35
0.55
4.3
4.8
1.1
1.5
mg/l
2.13
19
131
6
39
1.54
0.53
1.8
1.4
—
—
—
0
0
402
3894
1.08
0.42
6.1
7.3
73.0
81.8
u/l
5.94
373
3613
63
708
0.88
0.42
1.7
2.3
2.2
2.3
g/l
0.42
56
665
8
58
1.38
0.41
1.9
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
1.0
—
0
5
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
8
59
1.36
0.41
2.9
4.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
9
68
1.33
0.37
1.2
1.3
—
—
—
0
0
47
412
1.15
0.37
2.8
2.2
14.4
7.2
ug/l
0.51
42
370
10
135
0.74
0.36
1.6
1.6
—
—
—
0
0
133
1420
0.92
0.35
2.3
2.3
51.8
60.0
u/l
2.61
122
1285
69
629
1.11
0.31
7.8
6.0
—
—
—
0
0
75
687
1.10
0.31
1.2
1.2
39.1
45.0
iu/ml
0.09
19
212
111
1187
0.92
0.31
2.0
2.2
3.2
2.9
mg/l
0.72
91
1005
12
153
0.78
0.31
1.5
3.9
—
1.1
—
0
10
35
397
0.88
0.29
2.0
1.9
10.6
12.6
nmol/l
0.69
26
350
13
103
1.27
0.28
1.5
1.3
—
—
—
0
0
17
205
0.83
0.28
2.5
1.5
—
—
—
0
0
10
76
1.32
0.28
1.1
1.8
14.3
27.9
ug/l
—
10
76
10
76
1.32
0.28
1.7
1.5
—
—
—
0
0
36
406
0.88
0.28
2.1
2.8
126.5
59.1
ml/min/173m2
0.77
12
153
97
906
1.08
0.27
3.1
2.9
1.2
1.0
e6/l
0.35
71
539
505
5133
0.94
0.27
16.6
12.4
24.9
28.1
mg/l
1.11
437
3865
223
2314
0.95
0.26
3.2
3.9
—
—
—
0
0
179
1865
0.95
0.24
2.3
2.6
144.7
166.5
ug/l
0.87
164
1707
15
179
0.83
0.23
2.7
1.5
—
—
—
0
0
10
125
0.80
0.23
2.5
1.6
—
—
—
0
0
26
228
1.15
0.23
1.0
1.2
95.6
179.2
iu/ml
—
6
82
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
18
210
0.85
0.22
1.2
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
172
1.17
0.22
2.9
2.5
0.4
0.3
u/ml
0.31
13
95
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
283.0
—
0
7
7
58
1.21
0.18
1.0
1.0
—
—
—
0
0
63
668
0.94
0.16
1.8
2.3
22.4
23.0
%
0.14
57
583
8
70
1.14
0.16
1.1
1.4
—
—
—
0
0
116
1207
0.95
0.16
2.0
2.5
—
—
—
0
0
11
129
0.85
0.15
2.1
2.4
14.8
61.1
ug/min
—
5
76
8
99
0.81
0.13
1.1
1.4
—
—
—
0
0
51
536
0.95
0.11
2.2
2.6
8.4
9.2
umol/l
0.15
44
473
65
678
0.95
0.11
30.2
29.9
1.2
1.5
inr
—
10
85
15
135
1.11
0.09
4.3
3.0
26.2
28.4
mg/l
—
9
83
7
64
1.09
0.08
2.6
1.5
—
—
—
0
0
89
867
1.03
0.07
3.3
3.0
1.5
1.7
e6/l
0.12
62
503
8
78
1.03
0.07
2.4
1.5
—
—
—
0
0
444
4466
0.98
0.06
3.9
3.9
1.9
2.4
mu/l
0.86
408
3956
11
121
0.91
0.06
1.2
1.4
—
—
—
0
0
10
91
1.10
0.04
1.3
1.3
—
—
—
0
0
12
111
1.08
0.04
1.5
1.5
50.6
40.4
nmol/l
0.63
12
106
58
593
0.98
0.03
1.4
1.4
—
—
—
0
0
15
141
1.07
0.03
2.4
2.3
90.7
86.3
%
0.29
15
135
19
181
1.05
0.03
1.4
1.2
—
—
—
0
0
13
122
1.07
0.02
2.1
1.5
—
—
—
0
0
122
1230
0.99
0.02
4.2
3.3
0.0
0.0
estimate
0.50
40
385
13
123
1.06
0.01
1.5
1.4
—
—
—
0
0
13
125
1.04
0.00
1.4
1.1
—
—
—
0
0
13
126
1.03
0.00
1.4
1.1
—
—
—
0
0
76
757
1.00
0.00
1.9
2.4
13.7
12.7
umol/l
0.39
68
707
15
149
1.01
0.00
3.3
2.5
3.3
3.6
g/l
0.18
15
142
63
632
1.00
0.00
3.6
4.1
34.6
32.4
%
0.70
38
369
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
7
76
0.92
0.00
1.3
1.6
—
106.8
—
0
10
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
9
90
1.00
0.00
1.3
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
36.9
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
8.3
—
—
—
0
0
100
1000
1.00
0.00
3.7
3.1
1.0
1.0
kg/l
0.83
23
138
0
7
0.00
0.00
0.0
5.7
—
27.9
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MND – Motor neuron disease (with DMD)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).